e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical and functional evaluation of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessment of thyroid function tests in COPD phenotypes
A. YUKSEL (Ankara, Turkey), E. Akpinar (Ankara, Turkey), E. Sayin Gulensoy (Ankara, Turkey), N. Ogan (Ankara, Turkey), A. Alkan (Ankara, Turkey)
Source:
Virtual Congress 2020 – Clinical and functional evaluation of COPD
Session:
Clinical and functional evaluation of COPD
Session type:
E-poster session
Number:
543
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. YUKSEL (Ankara, Turkey), E. Akpinar (Ankara, Turkey), E. Sayin Gulensoy (Ankara, Turkey), N. Ogan (Ankara, Turkey), A. Alkan (Ankara, Turkey). Assessment of thyroid function tests in COPD phenotypes. 543
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The assessment of thyroid functions in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 486s
Year: 2001
Predictors of lung function deterioration in COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Prognostic assessment in COPD without lung function: the B-AE-D indices
Source: Eur Respir J 2016; 47:1635-1644
Year: 2016
Evaluation of swallowing function by two screening tests in primary COPD
Source: Eur Respir J 2009; 34: 280-281
Year: 2009
Clinical relevance of small airways assessment by lung function tests in asthma
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018
Novel lung function tests can improve phenotyping and differential therapy in COPD
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019
Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Relationships between COPD assessment test score and pulmonary function tests or quantitative CT analysis in Japanese COPD patients
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Relationship and responsiveness of muscular function and functional tests in patients with COPD
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in COPD and asthma
Year: 2014
Determination of the existence of a correlation between lung function decline and changes in the COPD assessment test
Source: International Congress 2014 – Clinical presentations
Year: 2014
Reversibility at pulmonary function tests: can it have implications in patients with COPD?
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Relationship between COPD assessment test (CAT) and declines of lung function in COPD patients
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012
Differences in functional impairment diagnosis using global lung initiative (GLI) predictive values for spirometry
Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages
Year: 2014
Scintigraphic parameters in COPD patients
Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked
Year: 2013
Assessment of different controller therapies in asthmatic children with pulmonary function tests
Source: Eur Respir J 2004; 24: Suppl. 48, 166s
Year: 2004
Role of the lung volume measurement in the diagnosis of obstructive diseases in patients with restrictive ventilatory impairment
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014
Features of COPD in correlation with COPD assessment test
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019
Evaluation of the relationship between laboratory parameters and pulmonary function tests in COVID-19 patients
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021
Bronchodilator response of advanced lung function parameters depending on COPD severity
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
The [bdquo]frequent exacerbator“ phenotype: Endothelial dysfunction and functional status
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept